Beruflich Dokumente
Kultur Dokumente
Cardiac complications
in pediatric patients
on the ketogenic diet
7. Van der Knaap MS, Barth PG, Stroink H, et al. Leukoencephalopathy with swelling and a discrepantly mild clinical course
in eight children. Ann Neurol 1995;37:324 334.
8. Hanefeld F, Holzbach U, Kruse B, Wilichowski, Christen H-J,
Frahm J. Diffuse white matter disease in three children: an
encephalopathy with unique features on magnetic resonance
imaging and proton magnetic resonance spectroscopy. Neuropediatrics 1993;24:244 248.
9. Schiffmann R, Moller JR, Trapp BD, et al. Childhood ataxia
with diffuse central nervous system hypomyelination. Ann
Neurol 1994;35:331340.
Article abstractCardiac complications of the ketogenic diet, in the absence of selenium deficiency, have not been reported. Twenty patients on the
ketogenic diet at one institution were investigated. Prolonged QT interval
(QTc) was found in 3 patients (15%). There was a significant correlation
between prolonged QTc and both low serum bicarbonate and high betahydroxybutyrate. In addition, three patients had evidence of cardiac chamber
enlargement. One patient with severe dilated cardiomyopathy and prolonged
QTc normalized when the diet was discontinued. Key words: Cardiac complicationsPediatric patientsKetogenic diet.
NEUROLOGY 2000;54:23282330
T.H. Best, MD; D.N. Franz, MD; D.L. Gilbert, MD; D.P. Nelson, MD, PhD; and M.R. Epstein, MD
The ketogenic diet (KD) is a high-fat, adequateprotein, low-carbohydrate intake designed to mimic
the biochemical changes of starvation. Many adverse
effects of KD have been reported.1,2 Cardiac abnormalities have not been described except when associated with selenium deficiency.3 Cardiovascular
deterioration of a child on KD prompted an investigation of this potential adverse effect in other children receiving this treatment.
Case report. A previously healthy boy presented at age
4 with partial seizures, exhibiting secondary generalization and status epilepticus. MRI scan revealed multifocal
areas of increased T2-weighted signal within the white
matter, which was believed to represent gliosis from a
remote insult. EEG demonstrated moderate background
slowing and right central epileptiform discharges. CSF,
serum, and urine metabolic screening was normal. After
failing phenytoin, high dose valproate, carbamazepine,
clonazepam, topiramate, ethosuximide, and lamotrigine,
KD was started. He tolerated this well and was weaned off
anticonvulsants. The initial fat to nonfat calorie ratio of
4:1 was eventually reduced to 3:1. Multivitamins, minerals, selenium, and carnitine supplements were given. Serum beta-hydroxybutyrate (BHB) levels of 4.4 to 6.9
mmol/L were achieved. He experienced a marked decrease
Figure 1. Electrocardiograms obtained before the initiation of the ketogenic diet (A), at the time of presentation
with congestive heart failure (B), and 1 month after the
ketogenic diet was discontinued (C), showing a QTc of
401, 542, and 404, respectively. The development of
marked reduction in QRS voltage on the ketogenic diet (B)
is also seen.
Methods. Patients currently on KD at Childrens Hospital Medical Center underwent screening ECGs, echocardiograms, and blood chemistries including BHB. Prior studies
were retrospectively reviewed. QT intervals were corrected
for rate by Bazetts formula (QTc QT/R R).4 Normal
QTc was defined as 450 for infants and 440 for children
and adolescents. Patients with ECG abnormalities underwent 24 to 48 hour ambulatory rhythm monitoring.
Nonparametric analysis of serum HCO3 and BHB versus QTc was performed using Spearman correlation coefficient. Correlation analysis included only blood levels and
ECGs obtained on the same day (n 9 patients, n 15
QTc, n 15 BHB, n 13 HCO3). A p value 0.05 was
considered significant.
Results. Twenty-one of 26 patients on KD were evaluated (mean age 9.8 4.7 years; range 1.0 to 19 years). One
patient was excluded because of tricyclic antidepressant
treatment. Three of 20 patients (15%, diet duration 13
NEUROLOGY 54
2329
2330 NEUROLOGY 54
June (2 of 2) 2000
Several factors may confound identification of cardiac dysfunction caused by KD. Seizure patients may
be less active than unaffected children or have cognitive impairment precluding assessment of exercise
tolerance. As demonstrated in the reported case,
transaminase elevation (often presumed to reflect
hepatic dysfunction associated with KD) may represent cardiac dysfunction and passive congestion of
the liver.
Biochemical alterations associated with KD may
cause important cardiac conduction changes in certain vulnerable children. Experience with other diets
creating a starvation-like state suggests that these
patients may be at increased risk for ventricular dysrhythmias and sudden death. Patients on KD should
be assessed before and during therapy with ECGs
and echocardiograms. It may also be useful to minimize excessive elevation of serum BHB and metabolic acidosis. A prospective investigation will be
necessary to further define the nature of this potentially serious side effect.
References
1. Freeman JM, Vining EP, Pillas DJ, et al. The efficacy of the
ketogenic diet 1998: a prospective evaluation of intervention
in 150 children. Pediatrics 1998;102:1358 1363.
2. Ballaban-Gil K, Callahan C, ODell C, et al. Complications of
the ketogenic diet. Epilepsia 1998;39:744 748.
3. Chee CM, Lutchka L, Brown L, Bergqvist C. Ketogenic diet:
unrecognized selenium deficiency. Epilepsia 1998;39(suppl 6):
228. Abstract.
4. Bazett HC. An analysis of the time-relations of electrocardiograms. Heart 1920;7:353370.
5. Ellis LB. Electrocardiographic abnormalities in severe malnutrition. Br Heart J 1946;8:53 61.
6. Pringle TH, Scobie IN, Murray RG, Kesson CM, Maccuish AC.
Prolongation of the QT interval during therapeutic starvation:
a substrate for malignant arrhythmias. Int J Obesity 1983;7:
253261.
7. Isner JM, Roberts WC, Heymsfield SB, Yager J. Anorexia
nervosa and sudden death. Ann Intern Med 1985;102:49 52.
8. Neve J. Selenium as a risk factor for cardiovascular diseases.
J Cardiovasc Risk 1996;3:42 47.
9. Nilsson L, Farahmand BY, Persson PG, Thiblin I, Tonson T.
Risk factors for sudden unexplained death in epilepsy: a casecontrol study. Lancet 1999;353:888 893.
10. Tavernor SJ, Brown SW, Tavernor RM, Gifford C. Electrocardiograph QT lengthening associated with epileptiform EEG
dischargesa role in sudden unexplained death in epilepsy?
Seizure 1996;5:79 83.